Type II NKT cells were also shown to suppress immunity against CD1d-transfected B cell lymphoma; amounts of IL-13, TGF-β, and MDSCs correlated with immune suppression (61). The gene discussed is CD1D; the disease is B-cell non-Hodgkin lymphoma.